Neurobiology of Disease (Oct 2015)

Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3

  • Li Zeng,
  • Bo Wang,
  • Sean A. Merillat,
  • Eiko N. Minakawa,
  • Matthew D. Perkins,
  • Biswarathan Ramani,
  • Sara J. Tallaksen-Greene,
  • Maria do Carmo Costa,
  • Roger L. Albin,
  • Henry L. Paulson

Journal volume & issue
Vol. 82
pp. 281 – 288

Abstract

Read online

Accumulation of mutant polyglutamine proteins in intraneuronal inclusions is a hallmark of polyglutamine diseases. Impairment of protein clearance systems and sequestration of clearance-related proteins into inclusions occur in many protein folding diseases, including polyglutamine diseases. The ubiquitin-binding and proteasome adaptor protein UBQLN2 participates in protein homeostasis and localizes to inclusions in various neurodegenerative diseases. Employing mouse models and human brain tissue of Huntington's disease (HD) and spinocerebellar ataxia type 3 (SCA3), we show that UBQLN2 is selectively recruited to inclusions in HD but not SCA3. Consistent with this result, in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2. Differential recruitment of UBQLN2 to aggregates in HD and SCA3 underscores the heterogeneity of inclusions in polyglutamine diseases and suggests that components of neuronal protein quality control may be differentially perturbed in distinct polyQ diseases.

Keywords